PD-1 combined with lenvatinib and TACE for the transformational treatment of hepatocellular carcinoma combined with portal vein tumor thrombus: a case report and literature review

PD-1 combined with lenvatinib and TACE for the transformational treatment of hepatocellular carcinoma combined with portal vein tumor thrombus: a case report and literature review

BackgroundThe prognosis of hepatocellular carcinoma combined with portal vein tumor thrombus is poor, with a median survival of only 3-6 months. PD-1 combined with targeted therapy may provide an opportunity for patients with BCLC C stage hepatocellular carcinoma combined with portal vein tumor thro...

Full description

Bibliographic Details
Main Authors: Sheng Liu, Rui Xiong, Chuanyi Duan, Jiang Tang, Tao Yin, Sisi Dai
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-10-01
Series:Frontiers in Oncology
Subjects:
PD-1
lenvatinib
hepatocellular carcinoma
portal vein tumor thrombus
TACE
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2023.1199143/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2023.1199143/full

Similar Items